4974 — Takara Bio Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Takara Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	25,993	23,633	51,847	35,416	29,549
Net Total Accounts Receivable
Net Total Receivables	12,585	17,804	12,448	11,285	14,017
Total Inventory
Total Other Current Assets
Total Current Assets	49,115	68,141	77,569	62,759	57,679
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29,766	36,395	40,956	49,075	56,954
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	89,750	115,712	129,202	121,252	125,334
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,191	17,380	14,375	7,168	7,131
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	15,568	19,839	16,983	9,747	9,835
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	74,182	95,873	112,219	111,505	115,499
Total Liabilities & Shareholders' Equity	89,750	115,712	129,202	121,252	125,334
Total Common Shares Outstanding